Jump to:
loading...| Preferred Name |
oritavancin |
|
| Synonyms |
|
|
| Definitions |
Oritavancin is a semi-synthetic derivative of chloroeremomycin, a vancomycin-like glycopeptide. Oritavancin inhibits both transglycosylation and transpeptidation, by binding both the D-Ala-D-Ala and pentaglycine bridge segments of peptidoglycan to inhibit cell wall formation. |
|
| ID |
http://purl.obolibrary.org/obo/ARO_3000189 |
|
| database_cross_reference |
pubchem.compound:16136912 |
|
| definition |
Oritavancin is a semi-synthetic derivative of chloroeremomycin, a vancomycin-like glycopeptide. Oritavancin inhibits both transglycosylation and transpeptidation, by binding both the D-Ala-D-Ala and pentaglycine bridge segments of peptidoglycan to inhibit cell wall formation. |
|
| has_obo_namespace |
antibiotic_resistance |
|
| id |
ARO:3000189 |
|
| label |
oritavancin |
|
| notation |
ARO:3000189 |
|
| prefLabel |
oritavancin |
|
| subClassOf |
Create mapping